These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19698823)

  • 21. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How much supervision is necessary for women taking mifepristone and misoprostol for early medical abortion?
    Shannon C; Winikoff B
    Womens Health (Lond); 2008 Mar; 4(2):107-11. PubMed ID: 19072508
    [No Abstract]   [Full Text] [Related]  

  • 24. Medication Abortion Up to 70 Days of Gestation.
    Practice Bulletins—Gynecology, the Society of Family Planning
    Contraception; 2020 Oct; 102(4):225-236. PubMed ID: 32807380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First trimester abortion with mifepristone and vaginal misoprostol.
    Knudsen UB
    Contraception; 2001 May; 63(5):247-50. PubMed ID: 11448463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore.
    Tan YL; Singh K; Tan KH; Gosavi A; Koh D; Abbas D; Winikoff B
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():144-147. PubMed ID: 30179732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
    Guengant JP; Bangou J; Elul B; Ellertson C
    Contraception; 1999 Sep; 60(3):167-72. PubMed ID: 10640161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortion.
    Ravn P; Rasmussen A; Knudsen UB; Kristiansen FV
    Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1098-102. PubMed ID: 16232179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions.
    Newhall EP; Winikoff B
    Am J Obstet Gynecol; 2000 Aug; 183(2 Suppl):S44-53. PubMed ID: 10944369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.
    Løkeland M; Bjørge T; Iversen OE; Akerkar R; Bjørge L
    Int J Epidemiol; 2017 Apr; 46(2):643-651. PubMed ID: 28031316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sonographic appearance of the uterine cavity following administration of mifepristone and misoprostol for termination of pregnancy.
    Markovitch O; Tepper R; Klein Z; Fishman A; Aviram R
    J Clin Ultrasound; 2006; 34(6):278-82. PubMed ID: 16788959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early versus late misoprostol administration after mifepristone for medical abortion.
    Tendler R; Bornstein J; Kais M; Masri I; Odeh M
    Arch Gynecol Obstet; 2015 Nov; 292(5):1051-4. PubMed ID: 25911546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous use of mifepristone and misoprostol for early pregnancy termination.
    Li YT; Hsieh JC; Hou GQ; Chen TH; Chu YC; Lin TC; Kuan LC; Lin M; Tang HH; Kuo TC
    Taiwan J Obstet Gynecol; 2011 Mar; 50(1):11-4. PubMed ID: 21482367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical abortion at 64 to 91 days of gestation: a review of 483 consecutive cases.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2003 May; 188(5):1315-9. PubMed ID: 12748505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review of more than one dose of misoprostol after mifepristone for abortion up to 10 weeks of gestation.
    Gallo MF; Cahill S; Castleman L; Mitchell EM
    Contraception; 2006 Jul; 74(1):36-41. PubMed ID: 16781258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of simultaneous use of mifepristone and misoprostol for early abortion.
    Li YT; Chen TH; Kuo TC
    Int J Gynaecol Obstet; 2008 Jun; 101(3):301. PubMed ID: 18289538
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
    Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
    Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.